Low Total T3 with Normal TSH, Total T4, and Free T4
The most likely cause is nonthyroidal illness syndrome (euthyroid sick syndrome), a physiologic adaptation to acute or chronic systemic illness that does not represent true thyroid disease and typically requires no treatment.
Understanding Nonthyroidal Illness Syndrome
This pattern—normal TSH, normal T4, normal free T4, but low total T3—is the hallmark laboratory signature of nonthyroidal illness syndrome, occurring in 60–70% of hospitalized or critically ill patients. 1, 2, 3
The low T3 results from decreased peripheral conversion of T4 to T3 by type 1 deiodinase (D1) enzymes, which is an adaptive metabolic response to conserve energy and protein during illness. 1, 4
Reverse T3 (rT3) levels are typically elevated in this syndrome because illness shifts T4 metabolism away from active T3 production toward inactive rT3 via type 3 deiodinase (D3). 4, 5, 3
Despite the low T3, patients remain clinically euthyroid with normal TSH levels, confirming that the hypothalamic-pituitary-thyroid axis recognizes this as an appropriate adaptation rather than true hypothyroidism. 1, 2
Clinical Context and Diagnostic Approach
Evaluate for underlying systemic illness, recent hospitalization, acute medical stress, or chronic disease—any of these can trigger this syndrome. 1, 2, 3
Common triggers include:
The normal TSH is the key discriminator: true primary hypothyroidism would show elevated TSH, whereas nonthyroidal illness maintains normal (or occasionally slightly suppressed) TSH. 1, 2
Free T4 remains normal in most cases of nonthyroidal illness, though it may be low in critically ill patients; your patient's normal free T4 strongly supports euthyroid sick syndrome over hypothyroidism. 1, 4
Medication-Induced Causes
Certain medications can produce this exact pattern by inhibiting T4-to-T3 conversion, most notably amiodarone, glucocorticoids, and dopamine. 6, 4
Amiodarone is a particularly important cause: it "inhibits peripheral conversion of thyroxine (T4) to triiodothyronine (T3) and may cause increased thyroxine levels, decreased T3 levels, and increased levels of inactive reverse T3 (rT3) in clinically euthyroid patients." 6
High-dose glucocorticoids and dopamine can suppress TSH secretion and impair peripheral T4-to-T3 conversion, creating a similar pattern. 4
Review the medication list carefully for these agents before attributing the findings solely to illness. 4
Differential Diagnosis: What This Is NOT
This pattern does NOT represent primary hypothyroidism, which would show elevated TSH with low free T4. 7
Subclinical hypothyroidism is defined as elevated TSH (>4.5 mIU/L) with normal free T4; your patient's normal TSH excludes this diagnosis. 7
Overt hypothyroidism requires both elevated TSH and low free T4; neither is present here. 7
Central (secondary) hypothyroidism would show low or inappropriately normal TSH with low free T4; your patient's normal free T4 excludes this. 7
Autoimmune Thyroid Disease Considerations
Positive thyroid antibodies (TPO, thyroglobulin, or TRAb) do NOT change the interpretation when TSH and free T4 are normal—they simply indicate future risk of thyroid dysfunction. 8
Patients with positive TPO antibodies have a 4.3% annual risk of developing overt hypothyroidism versus 2.6% in antibody-negative individuals, but this is a future risk, not a current diagnosis. 8
Current guidelines do not recommend levothyroxine treatment for normal thyroid function with positive antibodies alone, even when T3 is low due to nonthyroidal illness. 8
If antibodies are present, monitor TSH and free T4 every 6–12 months to detect progression to true hypothyroidism, but do not treat the current low T3. 8
Management Algorithm
Do NOT treat with levothyroxine or liothyronine (T3)—the low T3 is an adaptive response that protects against protein catabolism during illness. 1, 4
Confirm clinical euthyroidism: Look for absence of hypothyroid symptoms (fatigue, cold intolerance, weight gain, constipation) and absence of hyperthyroid symptoms (palpitations, tremor, heat intolerance). 1
Identify and treat the underlying illness: The thyroid pattern will normalize as the systemic illness resolves. 3
Recheck thyroid function after recovery: Repeat TSH, free T4, and total T3 3–6 weeks after resolution of acute illness to confirm normalization. 7, 3
If TSH remains normal and free T4 remains normal after recovery, no thyroid treatment is needed regardless of T3 level. 1
If TSH becomes elevated (>4.5 mIU/L) after recovery, this suggests unmasking of true hypothyroidism and warrants further evaluation. 7
Critical Pitfalls to Avoid
Never diagnose hypothyroidism based on low T3 alone—TSH and free T4 are the definitive tests. 1, 2
Serum T3 measurement "does not appear justified in patients with nonthyroidal disease" for diagnosing hypothyroidism because 70% of sick patients have low T3 despite being euthyroid. 2
Do not order reverse T3 (rT3) levels—while elevated rT3 confirms nonthyroidal illness, it adds no diagnostic or therapeutic value beyond what TSH and free T4 already provide. 5, 3
Avoid treating with T3 preparations based on low total T3 or elevated rT3; this practice lacks evidence and may cause harm by inducing iatrogenic hyperthyroidism. 5
Do not recheck thyroid function during acute illness—wait until metabolic stability is achieved, as serial testing during illness will show continued abnormalities that do not require treatment. 8
When to Suspect True Thyroid Disease
Reconsider the diagnosis if any of the following are present:
- TSH becomes elevated (>4.5 mIU/L) on repeat testing after illness resolution 7
- Free T4 is low (not just total T3) 7
- Clinical symptoms of hypothyroidism are prominent and persistent 7
- Patient has known autoimmune thyroid disease (Hashimoto's or Graves') with positive antibodies 8
- Patient is taking amiodarone and develops new symptoms, as "amiodarone can cause either hypothyroidism or hyperthyroidism" requiring different management 6
Evidence Quality
The interpretation of low T3 with normal TSH/T4 as nonthyroidal illness syndrome is supported by decades of consistent observational data showing this pattern in 60–70% of hospitalized patients who are clinically euthyroid. 1, 2, 3 The recommendation against treatment is based on physiologic understanding that the low T3 represents an adaptive energy-conserving response, plus the absence of evidence that T3 replacement improves outcomes in this setting. 1, 4